A Jeong Kim

A Jeong Kim

Auto-generated profile, based on publicly available information

A Jeong Kim

Department of Pharmacy, Seoul National University Hospital, Seoul 03080, Korea

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
AKA Jeong Kim
A Jeong Kim
HLHayeon Lee
Hayeon Lee
ESEun-Jeong Shin
Eun-Jeong Shin
ECEun-Jung Cho
Eun-Jung Cho
YCYoon Sook Cho
Yoon Sook Cho
JLJuyeun Lee
Juyeun Lee
Inappropriate polypharmacy is likely in older adults with chronic kidney disease (CKD) owing to the considerable burden of comorbidities. We aimed to describe the impact of pharmacist-led geriatric medication management service (MMS) on the quality of medication use. This retrospective descriptive study included 95 patients who received geriatric MMS in an ambulatory care clinic in a single tertiary-care teaching hospital from May 2019 to December 2019. The average age of the patients was 74.9 ± 7.3 years; 40% of them had CKD Stage 4 or 5. Medication use quality was assessed in 87 patients. After providing MMS, the total number of medications and potentially inappropriate medications (PIMs) decreased from 13.5 ± 4.3 to 10.9 ± 3.8 and 1.6 ± 1.4 to 1.0 ± 1.2 (both p < 0.001), respectively. Furthermore, the number of patients who received three or more central nervous system-active drugs and strong anticholinergic drugs decreased. Among the 354 drug-related problems identified, “missing patient documentation” was the most common, followed by “adverse effect” and “drug not indicated.” The most frequent intervention was “therapy stopped”. In conclusion, polypharmacy and PIMs were prevalent in older adults with CKD; pharmacist-led geriatric MMS improved the quality of medication use in this population.

14 July 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
YSYewon Suh
Yewon Suh
YAYoung-Mi Ah
Young-Mi Ah
HCHa-Jin Chun
Ha-Jin Chun
SLSu-Mi Lee
Su-Mi Lee
HKHyung-Sook Kim
Hyung-Sook Kim
JLJuyeun Lee
Juyeun Lee
Although specialized pharmacists have been suggested to be essential members of antimicrobial stewardship programs (ASPs), not all hospitals in Korea operate ASPs with pharmacists involved. We aimed to evaluate the association of involvement of clinical pharmacists as team members of multidisciplinary ASPs with the incidence of antimicrobial-related adverse drug events (ADEs). Five tertiary teaching hospitals participated in this retrospective cohort study. At each participating hospital, we randomly selected 1000 participants among patients who had received systemic antimicrobial agents for more than one day during the first quarter of 2017. We investigated five categories of antimicrobial-related ADEs: allergic reactions, hematologic toxicity, nephrotoxicity, hepatotoxicity, and antimicrobial-related diarrhea. Multivariate logistic regression analysis was used to evaluate the potential impact of pharmacist involvement in ASPs on the incidence of ADEs. A total of 1195 antimicrobial-related ADEs occurred in 618 (12.4%) of the 4995 patients included in the analysis. The overall rate of ADE occurrence was 17.4 per 1000 patient days. Hospitals operating ASPs with pharmacists showed significantly lower AE incidence proportions than other hospitals (8.9% vs. 14.7%; p < 0.001). Multidisciplinary ASPs that included clinical pharmacists reduced the risk of antimicrobial-related ADEs by 38% (adjusted odds ratio 0.62; 95% confidence interval 0.50–0.77). Our results suggest that the active involvement of clinical pharmacists in multidisciplinary ASPs may contribute to reduce the incidence of antimicrobial-related ADEs in hospitalized patients.

31 March 2021 in Journal of Pharmacoepidemiology and Risk Management
Verified
Journal Article
Open access
PDF file
YKYookyung Kim
Yookyung Kim
SKSung Eun Kim
Sung Eun Kim
AKA Jeong Kim
A Jeong Kim
MKMinjung Kim
Minjung Kim
ECEunjung Cho
Eunjung Cho
MDMd
Md

16 June 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
SPSoyoung Park
Soyoung Park
AKA Jeong Kim
A Jeong Kim
HCHyun-Woo Chae
Hyun-Woo Chae
KHKyu-Nam Heo
Kyu-Nam Heo
YKYookyung Kim
Yookyung Kim
JLJuyeun Lee
Juyeun Lee
Medication reconciliation (MR), which is widely implemented worldwide, aims to improve patient safety to reduce the medication errors during care transition. Despite its widespread use, MR has not yet been implemented in the Republic of Korea, and its effectiveness has not been studied. We aimed to evaluate the impact of a multidisciplinary MR service in older patients undergoing thoracic and cardiovascular surgery. This is a single-center, prospective, controlled, before-and-after study of adult patients taking at least one chronic oral medication. Depending on the period of each patient’s participation, they will be allocated to an intervention group or control group. Patients in the intervention group will receive multidisciplinary MR, and those in the control group will receive usual care. The primary outcome is to assess the impact of the MR service on medication discrepancies between the best possible medication history and medication orders at care transition. Secondary outcomes include the incidence rate of medication discrepancies at each transition, the discrepancy rate between the sources of information, the impact of MR on medication appropriateness index score, drug-related problems, 30-day mortality, the emergency department visit rate, readmission rate after discharge, the rate and acceptability of pharmacists’ intervention during hospitalization, and patients’ satisfaction.

30 September 2022 in Journal of Pharmacoepidemiology and Risk Management
Verified
Journal Article
Open access
PDF file
SPSeon Yeong Park
Seon Yeong Park
JBJeung-Uk Baek
Jeung-Uk Baek
KKKyung A Kim
Kyung A Kim
GCGo W Un Choi
Go W Un Choi
JBJin Hee Baek
Jin Hee Baek
MDMd
Md
Seon Yeong Park, BPharm, Jeung-Uk Baek, BPharm, Kyung A Kim, MS, Go W un Choi, MS, Jin Hee Baek, MS, Yun Hee Jo, PhD, Yoon Sook Cho, MS, Ho-Geol Ryu, MD, PhD, Ju-Yeun Lee, PhD and A Jeong Kim, PhD. Journal of Pharmacoepidemiology and Risk Management 2022;14:158-64. https://doi.org/10.56142/jperm.22.0015

1 January 2024 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
HCHyunwoo Chae
Hyunwoo Chae
SYSubin Yoon
Subin Yoon
SPSoyoung Park
Soyoung Park
AKA Jeong Kim
A Jeong Kim
KHKyu-Nam Heo
Kyu-Nam Heo
JLJuyeun Lee
Juyeun Lee
Aims: Medication discrepancies during transitions of care pose substantial risks, particularly in older patients receiving complex medication regimens. Obtaining the best possible medication history (BPMH) is crucial to minimize this risk. This study aimed to evaluate the effectiveness of a pharmacist‐led BPMH using various information sources including a nationwide medication history sharing program compared to conventional interviews in a tertiary hospital setting. In addition, we identified factors contributing to medication inaccuracies.Methods: A single‐center prospective study involving older patients scheduled for thoracic surgery at a tertiary hospital was conducted. Medication histories obtained through conventional interviews during the initial assessment on admission were compared with those obtained through BPMH by pharmacist‐led interviews. Logistic regression analysis was used to identify factors associated with medication inaccuracies.Results: This study included 216 patients, a significant proportion of whom were experiencing polypharmacy. The pharmacist‐led BPMH approach demonstrated superior accuracy in documenting medication histories, with conventional methods showing inaccuracies in over 70% of the cases. Factors that significantly increased the likelihood of inaccuracies included the number of medications and number of prescribers. Nonoral and as‐needed medications are particularly prone to inaccuracies.Conclusions: Pharmacist‐led BPMH significantly improved medication history accuracy compared to conventional methods, which had inaccuracies in over 70%. It is important to be careful when obtaining BPMH for older adults, particularly those with complex medication regimens, nonoral medications, or PRN medications, to enhance patient safety and reduce medication‐related risks.Trial Registration: Clinical Trial Registry identifier: KCT-006813.